These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
552 related articles for article (PubMed ID: 16584440)
1. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Schonewille H; van de Watering LM; Brand A Transfusion; 2006 Apr; 46(4):630-5. PubMed ID: 16584440 [TBL] [Abstract][Full Text] [Related]
2. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Schonewille H; de Vries RR; Brand A Transfusion; 2009 Mar; 49(3):453-7. PubMed ID: 19243541 [TBL] [Abstract][Full Text] [Related]
3. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Tormey CA; Fisk J; Stack G Transfusion; 2008 Oct; 48(10):2069-76. PubMed ID: 18631165 [TBL] [Abstract][Full Text] [Related]
4. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus. Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657 [TBL] [Abstract][Full Text] [Related]
5. Detection of anti-D in D- recipients transfused with D+ red blood cells. Yazer MH; Triulzi DJ Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Natukunda B; Schonewille H; van de Watering L; Brand A Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889 [TBL] [Abstract][Full Text] [Related]
7. The production of red blood cell alloantibodies in mice transfused with blood from transgenic Fyb-expressing mice. Campbell-Lee SA; Liu J; Velliquette RW; Halverson GR; Shirey RS; Chaudhuri A; Reid ME; Ness PM; Baldwin WM Transfusion; 2006 Oct; 46(10):1682-8. PubMed ID: 17002623 [TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Natukunda B; Schonewille H; Ndugwa C; Brand A Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949 [TBL] [Abstract][Full Text] [Related]
9. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570 [TBL] [Abstract][Full Text] [Related]
10. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746 [TBL] [Abstract][Full Text] [Related]
11. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity. Schonewille H; van de Watering LM; Loomans DS; Brand A Transfusion; 2006 Feb; 46(2):250-6. PubMed ID: 16441603 [TBL] [Abstract][Full Text] [Related]
12. Red blood cell alloimmunization in transfusion-dependent Egyptian patients with thalassemia in a limited donor exposure program. el-Danasoury AS; Eissa DG; Abdo RM; Elalfy MS Transfusion; 2012 Jan; 52(1):43-7. PubMed ID: 21745214 [TBL] [Abstract][Full Text] [Related]
13. Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Zalpuri S; Zwaginga JJ; le Cessie S; Elshuis J; Schonewille H; van der Bom JG Vox Sang; 2012 Feb; 102(2):144-9. PubMed ID: 21729098 [TBL] [Abstract][Full Text] [Related]
14. Transfusion management of sickle cell patients during bone marrow transplantation with matched sibling donor. McPherson ME; Anderson AR; Haight AE; Jessup P; Castillejo MI; Hillyer CD; Josephson CD Transfusion; 2009 Sep; 49(9):1977-86. PubMed ID: 19453984 [TBL] [Abstract][Full Text] [Related]
15. Frequency and specificity of red cell antibodies in thalassemia patients in Albania. Seferi I; Xhetani M; Face M; Burazeri G; Nastas E; Vyshka G Int J Lab Hematol; 2015 Aug; 37(4):569-74. PubMed ID: 25865362 [TBL] [Abstract][Full Text] [Related]
16. Clinically significant red blood cell antibodies in chronically transfused patients: a survey of Chinese thalassemia major patients and literature review. Cheng CK; Lee CK; Lin CK Transfusion; 2012 Oct; 52(10):2220-4. PubMed ID: 22339270 [TBL] [Abstract][Full Text] [Related]
17. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522 [TBL] [Abstract][Full Text] [Related]
18. Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study). Schonewille H; Honohan Á; van der Watering LM; Hudig F; Te Boekhorst PA; Koopman-van Gemert AW; Brand A Transfusion; 2016 Feb; 56(2):311-20. PubMed ID: 26442648 [TBL] [Abstract][Full Text] [Related]
19. Does an alloimmune response to strong immunogenic red blood cell antigens enhance a response to weaker antigens? Schonewille H; Brand A Transfusion; 2008 May; 48(5):958-63. PubMed ID: 18454736 [TBL] [Abstract][Full Text] [Related]
20. Effects of prophylactic red blood cell (RBC) transfusion with extended antigen matching on alloimmunization in patients with Sickle Cell Disease (SCD). Leal I; Dos Santos TD; Gilli S; Castilho L Transfus Apher Sci; 2023 Dec; 62(6):103813. PubMed ID: 37743224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]